Two Sigma Advisers
GMAB icon

Two Sigma Advisers’s Genmab GMAB Stock Holding History

Two Sigma Advisers’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-340,000
Closed -$10.5M – 881
2025
Q4 		$10.5M Sell
340,000
-1,092,800
-76% -$34.1M 0.02% 527
2025
Q3 		$43.9M Sell
1,432,800
-388,200
-21% -$9.46M 0.09% 188
2025
Q2 		$37.6M Sell
1,821,000
-152,700
-8% -$3.13M 0.08% 227
2025
Q1 		$38.6M Buy
1,973,700
+320,200
+19% +$6.72M 0.09% 220
2024
Q4 		$34.5M Buy
1,653,500
+1,038,400
+169% +$22.8M 0.08% 212
2024
Q3 		$15M Buy
615,100
+280,900
+84% +$7.51M 0.04% 383
2024
Q2 		$8.4M Buy
334,200
+276,900
+483% +$7.85M 0.02% 589
2024
Q1 		$1.71M Buy
+57,300
New +$1.68M ﹤0.01% 1301
2021
Q2 		– Sell
-78,500
Closed -$2.58M – 2542
2021
Q1 		$2.58M Buy
78,500
+19,500
+33% +$733K 0.01% 1147
2020
Q4 		$2.4M Sell
59,000
-40,600
-41% -$1.52M 0.01% 1158
2020
Q3 		$3.65M Sell
99,600
-51,400
-34% -$1.86M 0.01% 880
2020
Q2 		$5.12M Buy
+151,000
New +$4.11M 0.02% 783

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Two Sigma Advisers's GMAB Position: Q1 2026 in Review

Two Sigma Advisers sold out of Genmab (GMAB) in Q1 2026, closing a stake of 340,000 shares — an estimated $10.5M sold.

Two Sigma Advisers first reported a position in GMAB in Q2 2020 and held it in 12 quarters. The position peaked at $43.9M in Q3 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Two Sigma Advisers reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 340,000 Genmab shares in Q1 2026, an estimated $10.5M.
  • Two Sigma Advisers first reported a position in Genmab in Q2 2020 and held it in 12 quarters.
  • Two Sigma Advisers's Genmab position peaked at $43.9M in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.